Sézary disease: Difference between revisions
m clean up, Replaced: ® → using AWB |
No edit summary |
||
| Line 1: | Line 1: | ||
{{DiseaseDisorder infobox | |
{{DiseaseDisorder infobox | |
||
Name = Sézary |
Name = Sézary disease | |
||
ICD10 = {{ICD10|C|84|1|c|81}} | |
ICD10 = {{ICD10|C|84|1|c|81}} | |
||
ICD9 = {{ICD9|202.2}} | |
ICD9 = {{ICD9|202.2}} | |
||
Revision as of 02:35, 4 June 2008
| Sézary disease | |
|---|---|
| Specialty | Oncology  |
Sézary's disease (often named Sézary syndrome) is a type of cutaneous lymphoma which was first described by Albert Sézary.[1] The affected cells are T-cells that have pathological quantities of mucopolysaccharides. Sézary's disease is sometimes considered a late stage of mycosis fungoides.[2][3] There are currently no known causes of Sézary's disease.[4]
Signs and symptoms
Sézary syndrome and mycosis fungoides are T-cell lymphomas whose primary manifestation is in the skin. The disease's origin is a peripheral CD4+ T-lymphocyte[2], although rarer CD8+/CD4- cases have been observed.[2] Epidermotropism by neoplastic CD4+ lymphocytes with the formation of Pautrier's microabscesses is the hallmark sign of the disease.[2] The dominant symptoms of the disease are:
- Generalized erythroderma[2]
- Lymphadenopathy[2]
- Atypical T-cells ("Sézary cells") in the peripheral blood[2]
- Hepatosplenomegaly[5]
Diagnosis
Patients who have Sézary's disease often present with skin lesions that do not heal with normal medication.[6] A blood test generally reveals any change in the levels of lymphocytes in the blood which is often associated with a cutaneous T-cell lymphoma.[6] Finally, a biopsy of a skin lesion can be performed to rule out any other causes.[6]
Treatment
Vorinostat (Zolinza) is a second-line drug for cutaneous T-cell lymphoma.[citation needed] Treatments are often used in combination with phototherapy and chemotherapy.[2]
Epidemiology
Mycosis fungoides is the most common form of cutaneous T-cell lymphoma.[2] In the western population there are around 0.3 cases of Sezary syndrome per 100,000 people.[2] Sézary disease is more common in males with a ratio of 2:1,[2] and the mean age of diagnosis is between 55 and 60 years of age.[2] Patients with Sézary disease have a median survival of 5 years.[5]
References
- ^ synd/3594 at Who Named It?
- ^ a b c d e f g h i j k l Cuneo A, Castoldi. "Mycosis fungoidses/Sezary's syndrome". Retrieved 2008-02-15.
- ^ Thangavelu, Maya. "Recurring Structural Chromosome Abnormalities in Peripheral Blood Lymphocytes of Patients With Mycosis Fungoides/Sézary Syndrome". Retrieved 2008-02-15.
- ^ "Causes and Symptoms". Retrieved 2008-02-15.
- ^ a b Lorincz, A. I. "Sezary syndrome". Retrieved 2008-02-15.
- ^ a b c "Diagnosis". Retrieved 2008-02-15.
External links
- Illustration of Sezary cells
- Illustration of Sezary cells
- Biography of Sezary (in French)
- Sezary Syndrome lymphoma information
- Doctor's doctor
- Cutaneous Lymphoma Foundation
- [http://www.clinicaltrials.gov/ct/show/NCT00106431 Clinical Trial for Sezary Syndrome
 | This article about a disease, disorder, or medical condition is a stub. You can help Wikipedia by expanding it. |